![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 05, 2014 7:24:38 PM
..........that in his opinion CEO made the correct and bold move by restructuring the crux of this company by moving into the compounding drug niche. It would not surprise me if CEO were looking for other companies similar to Main Avenue to acquire..........and let us not forget our other revenue streams. I would agree with my fellow longs that we can easily be between $1.50-$2 given the numbers company is doing on compounding alone and then factor in the other revenue streams. This is a long term hold and an excellent buy at this price
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM